(Q51363512)
Statements
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. (English)
1 reference
Jeffrey A Pfefferkorn
1 reference
Angel Guzman-Perez
1 reference
John Litchfield
1 reference
Robert Aiello
1 reference
Judith L Treadway
1 reference
John Pettersen
1 reference
Martha L Minich
1 reference
Kevin J Filipski
1 reference
Christopher S Jones
1 reference
Meihua Tu
1 reference
Gary Aspnes
1 reference
Hud Risley
1 reference
Jianwei Bian
1 reference
Benjamin D Stevens
1 reference
Patricia Bourassa
1 reference
Theresa D'Aquila
1 reference
Levenia Baker
1 reference
Nicole Barucci
1 reference
Alan S Robertson
1 reference
Francis Bourbonais
1 reference
David R Derksen
1 reference
Margit Macdougall
1 reference
Over Cabrera
1 reference
Jing Chen
1 reference
Amanda Lee Lapworth
1 reference
James A Landro
1 reference
William J Zavadoski
1 reference
Karen Atkinson
1 reference
Nahor Haddish-Berhane
1 reference
Beijing Tan
1 reference
Lili Yao
1 reference
Rachel E Kosa
1 reference
Manthena V Varma
1 reference
Bo Feng
1 reference
David B Duignan
1 reference
Ayman El-Kattan
1 reference
Sharad Murdande
1 reference
Shenping Liu
1 reference
Mark Ammirati
1 reference
John Knafels
1 reference
Paul Dasilva-Jardine
1 reference
Laurel Sweet
1 reference
Spiros Liras
1 reference
Timothy P Rolph
1 reference
24 January 2012
1 reference
55
1 reference
3
1 reference
1318-1333
1 reference